By Mike Barr Even the researchers admit any definitive conclusions must await more rigorous investigation. But on the eve of World AIDS Day the news of a possible novel, less onerous, and much more affordable approach to the treatment of…
Why the Tap 'n' Drainers Have Always Been Wrong; Plus, a New Theory About MDR HIV By Richard Jefferys The Primacy of Immune Activation Project Inform, the country's longest serving community-based AIDS treatment information organization, has been sponsoring scientific think…
Vaccine Scientists Struggle to Come to Grips With the Field's "Berlin" By Richard Jefferys Technologically Challenged? The AIDS Vaccines 2004 Conference was held from August 30-September 1 in Lausanne, Switzerland, the first of these meetings to be held outside the…
Gilead 2-in-1 Opens Door to Impending One-Pill Triple Combo By Rob Camp GSK's, a Sort of Snoozer In early August the FDA announced the approvals of two fixed-dose combination (FDC) antiretroviral drug products. FDCs are combinations of two previously approved…
Veteran NEJM Editor Takes on Big Pharma as No One Before; Calls for Sweeping Reforms Party Pooper "I find it hard to imagine that a system this corrupt can be a good thing, or that it is worth the…
Thai Activist Exhorts Conference Crowd to Stand Firm Against U.S. Patent Regime and "Masks of Fake Concern" By Paisan Suwannawong "Trading Away Health" The following is the text of an address delivered by Thai AIDS Treatment Action Group director Paisan…
How to Get 6 Million Poor People on Antiretroviral Therapy -- and 1 Million Rich People Off In a brief July editorial, "Freedom of Choice," UK-based AIDS Treatment Update editor Edwin Bernard captures the essence of the present day therapeutic…
More Mixes Nixed By Concentration Preoccupations By Yasmin Halima and Rob Camp Statin Strength Relative Potency of the HMG-CoA Reductase Inhibitors (a.k.a. Statins) Drug Daily Dose Relative Potency* Fluvastatin (Lescol) 60 mg 1 Pravastatin (Pravachol) 60 mg 2 Lovastatin (Mevacor) 20 mg 3…
French Researchers Question Benefit of Lifelong Antiretroviral Treatment The following are excerpts from "Effect of highly active antiretroviral therapy over 5 years," Jean-Pierre Viard and colleagues (Service d'Immunologie Clinique, Centre Hospitalier Universitaire Necker-Enfants Malades, Paris). It is more and more…
Treatment Advocates Strategize At TAG's 2nd Annual International TB/HIV Workshop Activists From 31 Countries Building on the success of the First International TB/HIV Community Education and Mobilization Workshop, held in conjunction with the 33rd International Union Against Tuberculosis and Lung…